Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioconjugate Chemistry|December 13, 2007
Amino acid analysis of peptide loading ratios in conjugate vaccines: a comparison of direct electrochemical detection and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate pre-column derivatization methodsDeborah D Nahas, Jennifer S Palladino, Joseph G Joyce, et al.
Experimental Neurology|September 12, 2009
Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse modelRenee C Gaspar, Stephanie A Villarreal, Nicole Bowles, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197Ivette Caro-Aguilar, Elizabeth Ottinger, Robert W Hepler, et al.
Biochemistry|December 21, 2006
Solution state characterization of amyloid beta-derived diffusible ligandsRobert W Hepler, Karen M Grimm, Deborah D Nahas, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2011
High throughput monitoring of amyloid-β(42) assembly into soluble oligomers achieved by sensitive conformation state-dependent immunoassaysWei-Qin Zhao, Dawn Toolan, Robert W Hepler, et al.
Protein Science : a Publication of the Protein Society|August 26, 2018
Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidationRobert W Hepler, Debbie D Nahas, Bob Lucas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2024
Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidatesChengwei Wu, Izzat T Raheem, Debbie D Nahas, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeGayathri Bommakanti, Michael P Citron, Robert W Hepler, et al.
The Journal of Biological Chemistry|October 15, 2010
Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leadsMichael J Caulfield, Vadim Y Dudkin, Elizabeth A Ottinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolatesElisabetta Bianchi, Joseph G Joyce, Michael D Miller, et al.
Pageof 2